Skip to main content
Miracle Leaf

Miracle Leaf® qualifying-conditions guide

Medical Marijuana for Traumatic Brain Injury

Injury to the brain caused by external force, ranging from mild concussion to severe disability. Cannabis evidence for TBI is limited; observational data suggest possible benefit for chronic headache, sleep disturbance, mood symptoms, and chronic pain following TBI.

Reviewed by Miracle Leaf® Editorial Team

Last reviewed 2026-05-16

NASEM evidence levelLimitedICD-10: S06.9X9A

What is Traumatic Brain Injury?

Traumatic brain injury (TBI) is brain dysfunction caused by external mechanical force, including blunt impact, penetrating injury, blast exposure, or rapid acceleration-deceleration. Severity ranges from mild (concussion, with brief or no loss of consciousness) to severe (extended unconsciousness or amnesia, structural brain damage). Common chronic sequelae include persistent post-concussive symptoms (headache, dizziness, cognitive impairment), chronic pain, sleep disturbance, mood disorders, post-traumatic stress, and seizure disorders.

Does cannabis help Traumatic Brain Injury?

Cannabis evidence for TBI is limited at the disease level but stronger at the symptom level. Several of the most common chronic post-TBI symptoms (chronic pain, sleep disturbance, anxiety, PTSD-overlap symptoms, spasticity in severe TBI) overlap with conditions for which cannabis has moderate-to-substantial evidence per the 2017 NASEM report.

Preclinical research on endocannabinoid system involvement in neuroprotection, neuroinflammation, and neuroplasticity has been active for over two decades. This has not translated to a clinical disease-modifying therapy. Clinical use of cannabis in TBI is currently symptom-targeted rather than disease-modifying.

Practical considerations

Cannabis can interact with TBI medications including opioids, benzodiazepines, anticonvulsants, and sleep medications through additive CNS depression. Cognitive effects of cannabis (working-memory and attention impairment with acute intoxication) overlap with common TBI cognitive deficits; patients should evaluate net function carefully, particularly during work or driving.

Veterans with TBI frequently have co-occurring PTSD and chronic pain; cannabis use in this population is well-documented but should be coordinated with VA or civilian neurology, mental-health, and pain-management teams. Smoked cannabis is generally not recommended in patients with seizure disorder secondary to TBI given variability in delivered dose and inflammatory effects.

Important: patients with TBI should not substitute cannabis for prescribed seizure prophylaxis, antidepressants, or cognitive-rehabilitation regimens without coordinating with their treatment team.

Eligibility

State eligibility for Traumatic Brain Injury

Whether this condition is listed varies by state program. A Miracle Leaf® physician determines eligibility during your evaluation.

State-by-state eligibility for Traumatic Brain Injury: whether the condition qualifies under Florida, Georgia, and Texas medical cannabis programs.
StateQualifies?Program
FloridaNot listedFlorida OMMU
GeorgiaNot listedGeorgia DPH Low-THC Registry
TexasYesTexas Compassionate Use Program
Outside Florida, Georgia, or Texas?

Telehealth visits are available in 22 states. See telehealth states

Common questions

Frequently asked questions

How strong is the cannabis evidence for traumatic brain injury?
Limited. The 2017 NASEM consensus report did not identify high-tier evidence for cannabis specifically in TBI. Most patient use is adjunctive for chronic post-TBI symptoms (chronic headache, chronic pain, sleep disturbance, anxiety, PTSD-overlap symptoms). Preclinical data on cannabinoid neuroprotection has not translated to clear acute clinical benefit.
Is any cannabis-derived product FDA-approved for TBI?
No. No cannabis or cannabinoid product is FDA-approved for traumatic brain injury or post-concussive syndrome. Standard TBI care uses symptom-targeted therapy (analgesics, antidepressants, anxiolytics, cognitive rehabilitation, vestibular therapy) plus disease-modifying intervention when applicable.
Which TBI-related symptoms have the most cannabis-related evidence?
Chronic pain (including post-traumatic headache), sleep disturbance, and mood symptoms (anxiety, depression) have the most consistent patient-reported support. Each of these underlying symptoms has stronger NASEM-recognized evidence as a stand-alone target than does TBI as a whole.
Which states qualify TBI for medical cannabis?
Several states explicitly list TBI as a qualifying condition (Ohio, Connecticut, Minnesota, and others). Practitioner-discretion states (Oklahoma, New York post-2022, Missouri, Virginia post-2023) can certify for TBI within the discretion standard. States that recognize severe chronic pain or PTSD often capture TBI-related symptoms within those categories.

Ready to talk with a Miracle Leaf® physician?

Reviewed by Miracle Leaf® Editorial Team. This page summarizes current peer-reviewed evidence and federal guidance and is updated when the source documents materially change.